Literature DB >> 9350738

Molecular epidemiology of varicella-zoster virus in East London, England, between 1971 and 1995.

K Hawrami1, I J Hart, F Pereira, S Argent, B Bannister, B Bovill, D Carrington, M Ogilvie, S Rawstorne, Y Tryhorn, J Breuer.   

Abstract

The molecular epidemiology of varicella-zoster virus in London, England, between 1971 and 1995 was examined by using two informative polymorphic markers, variable repeat region R5 and a BglI restriction site in gene 54. Viruses from 105 cases of chickenpox and 144 of zoster were typed. Two alleles of R5, A and B, were found at prevalences of 89 and 6%, respectively. No difference in allele frequency between the zoster and chickenpox cases was found, and no change in the frequencies of these alleles was observed to occur over time. By contrast, a BglI restriction site (BglI+) was found with increasing frequency over time among cases of varicella (P < 0.005) and, to a lesser extent, cases of zoster. The BglI+ polymorphism was strongly associated (P < 0.0005) with zoster in subjects who had immigrated to the United Kingdom from countries with low adult immunity to varicella (LAIV). Sixty-three percent of the subjects with zoster who had emigrated from countries with LAIV carried the BglI+ virus, in contrast to 10% of adults who had grown up in countries with high adult immunity to varicella. The significance of these data, in view of the changing epidemiology of chickenpox, is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350738      PMCID: PMC230066          DOI: 10.1128/jcm.35.11.2807-2809.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Restriction fragment differences between the genomes of the Oka varicella vaccine virus and American wild-type varicella-zoster virus.

Authors:  S G Adams; D E Dohner; L D Gelb
Journal:  J Med Virol       Date:  1989-09       Impact factor: 2.327

2.  Recombination in tissue culture between varicella-zoster virus strains.

Authors:  D E Dohner; S G Adams; L D Gelb
Journal:  J Med Virol       Date:  1988-03       Impact factor: 2.327

3.  Varicella-zoster virus epidemiology--a changing scene?

Authors:  C K Fairley; E Miller
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

4.  Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults.

Authors:  L D Gelb; D E Dohner; A A Gershon; S P Steinberg; J L Waner; M Takahashi; P H Dennehy; A E Brown
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

5.  Differentiation of oka varicella vaccine strain from wild varicella-zoster virus strains isolated from vaccinees and household contact.

Authors:  K Shiraki; K Horiuchi; Y Asano; K Yamanishi; M Takahashi
Journal:  J Med Virol       Date:  1991-02       Impact factor: 2.327

6.  Distribution of varicella-zoster virus strains carrying a PstI-site-less mutation in Japan and DNA change responsible for the mutation.

Authors:  R Hondo; Y Yogo; M Yoshida; A Fujima; S Itoh
Journal:  Jpn J Exp Med       Date:  1989-12

7.  The age of infection with varicella-zoster virus in St Lucia, West Indies.

Authors:  G P Garnett; M J Cox; D A Bundy; J M Didier; J St Catharine
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

8.  Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates.

Authors:  P LaRussa; O Lungu; I Hardy; A Gershon; S P Steinberg; S Silverstein
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  Strain variation of R5 direct repeats in the right-hand portion of the long unique segment of varicella-zoster virus DNA.

Authors:  R Hondo; Y Yogo
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Genome differences among varicella-zoster virus isolates.

Authors:  S E Straus; J Hay; H Smith; J Owens
Journal:  J Gen Virol       Date:  1983-05       Impact factor: 3.891

View more
  8 in total

1.  Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination.

Authors:  Winsome Barrett Muir; Richard Nichols; Judith Breuer
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes.

Authors:  V N Loparev; K McCaustland; B P Holloway; P R Krause; M Takayama; D S Schmid
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Genotype of varicella-zoster virus isolates in South Korea.

Authors:  Kye-Hyung Kim; Young Ju Choi; Kyoung-Ho Song; Wan Beom Park; Jae-Hyun Jeon; Sang-Won Park; Hong Bin Kim; Nam Joong Kim; Myoung-Don Oh
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

4.  Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR.

Authors:  V N Loparev; T Argaw; P R Krause; M Takayama; D S Schmid
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

5.  Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping.

Authors:  Vladimir N Loparev; Antonio Gonzalez; Marlene Deleon-Carnes; Graham Tipples; Helmut Fickenscher; Einar G Torfason; D Scott Schmid
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002.

Authors:  Gustavo H Dayan; María S Panero; Roberto Debbag; Ana Urquiza; Marta Molina; Susana Prieto; María Del Carmen Perego; Graciela Scagliotti; Diana Galimberti; Guillermo Carroli; Cristina Wolff; D Scott Schmid; Vladimir Loparev; Dalya Guris; Jane Seward
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

Review 7.  A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008.

Authors:  Judith Breuer; Charles Grose; Peter Norberg; Graham Tipples; D Scott Schmid
Journal:  J Gen Virol       Date:  2010-01-13       Impact factor: 3.891

8.  Rates of vaccine evolution show strong effects of latency: implications for varicella zoster virus epidemiology.

Authors:  Lucy A Weinert; Daniel P Depledge; Samit Kundu; Anne A Gershon; Richard A Nichols; Francois Balloux; John J Welch; Judith Breuer
Journal:  Mol Biol Evol       Date:  2015-01-06       Impact factor: 8.800

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.